All Stories

  1. Efficacy and tolerability of BP-C1 in metastatic breast cancer: a Phase II, randomized, double-blind, and placebo-controlled Thai multi-center study

    Article • Breast Cancer Targets and Therapy, January 2019, Dove Medical Press

    Kritiya Butthongkomvong, Stig Larsen

  2. Randomized response surface pathway design with odd response outcomes in a Latin Square designed study

    Article • Open Access Journal of Clinical Trials, September 2017, Dove Medical Press

    Stig Larsen

  3. Development of a randomized two-dimensional response surface pathway design with two interventional and one response variables

    Article • Open Access Journal of Clinical Trials, October 2016, Dove Medical Press

    Stig Larsen

  4. BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum]

    Article • Breast Cancer Targets and Therapy, June 2015, Taylor & Francis

    Mrs Elena Vladimirovna Poddubskaya, Stig Larsen, Kritiya Butthongkomvong

  5. Positive effects on hematological and biochemical imbalances in patients with metastatic breast cancer stage IV, of BP-C1, a new anticancer substance

    Article • Drug Design Development and Therapy, March 2015, Taylor & Francis

    Stig Larsen

  6. BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

    Article • Breast Cancer Targets and Therapy, November 2014, Taylor & Francis

    Mrs Elena Vladimirovna Poddubskaya, Stig Larsen, Kritiya Butthongkomvong